This NIDA Avenir Award Program is designed to support early-stage investigators proposing highly innovative research into the genetics or epigenetics of substance use disorders. Named ‘Avenir’ (future) to reflect its forward-looking goal, this grant aims to foster tomorrow’s leaders in the field. It specifically targets researchers who may not yet have the preliminary data typically required for an R01 grant, but who demonstrate exceptional promise and the potential for high-impact discoveries. This grant is for aspiring scientists poised to make significant advancements in understanding the genetic and epigenetic underpinnings of substance use disorders, supporting projects that, while innovative, might lack extensive preliminary data but show clear potential for groundbreaking contributions.
Opportunity ID: 327417
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-20-225 |
| Funding Opportunity Title: | Avenir Award Program for Genetics or Epigenetics of Substance Use Disorders (DP1 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jun 01, 2020 |
| Last Updated Date: | Jun 01, 2020 |
| Original Closing Date for Applications: | Oct 19, 2022 |
| Current Closing Date for Applications: | Oct 19, 2022 |
| Archive Date: | Nov 24, 2022 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $300,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Independent school districts Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) Public housing authorities/Indian housing authorities Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Native American tribal organizations (other than Federally recognized tribal governments) State governments County governments Small businesses Private institutions of higher education For profit organizations other than small businesses Special district governments City or township governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | Avenir means future in French, and this award looks toward the future by supporting early stage investigators proposing highly innovative studies. The award will support those in an early stage of their career who may lack the preliminary data required for an R01 grant, but who propose high impact research and who show promise of being tomorrow’s leaders in the field. NIDA has developed two Avenir Award Programs, one for HIV/AIDS research and the other for genetics or epigenetics studies. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-20-225.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 327417 Full Announcement-PAR-20-225 -> PAR-20-225-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-F | Use for due dates on or before January 24, 2022 | PKG00261988 | Sep 19, 2020 | Jan 24, 2022 | View | |
| FORMS-G | Use for due dates on or after January 25, 2022 | PKG00269570 | Oct 27, 2021 | Oct 19, 2022 | View |
Package 1
Mandatory forms
327417 RR_SF424_2_0-2.0.pdf
327417 PHS398_CoverPageSupplement_5_0-5.0.pdf
327417 RR_OtherProjectInfo_1_4-1.4.pdf
327417 PerformanceSite_2_0-2.0.pdf
327417 RR_KeyPersonExpanded_2_0-2.0.pdf
327417 PHS398_ResearchPlan_4_0-4.0.pdf
327417 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
327417 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
327417 RR_SF424_5_0-5.0.pdf
327417 PerformanceSite_4_0-4.0.pdf
327417 RR_OtherProjectInfo_1_4-1.4.pdf
327417 RR_KeyPersonExpanded_4_0-4.0.pdf
327417 PHS398_CoverPageSupplement_5_0-5.0.pdf
327417 PHS398_ResearchPlan_4_0-4.0.pdf
327417 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
327417 PHS_AssignmentRequestForm_3_0-3.0.pdf
327417 RR_Budget10_3_0-3.0.pdf
327417 RR_SubawardBudget10_30_3_0-3.0.pdf
327417 PHS398_ModularBudget_1_2-1.2.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
